Callisia Clarke, Krittiya Korphaisarn, Zhiqin Jiang, Shadarra Crosby, Darren W. Davis, Weiguo Wu, Kanwal Pratap Singh Raghav, Michael J. Overman, Van Karlyle Morris, Bryan K. Kee, Cathy Eng, David R. Fogelman, Nicholas Navin, Scott Kopetz. “Antibody-independent isolation and characterization of circulating tumor cells using dielectrophoresis: Fluid flow fractionation in metastatic colorectal cancer.”  Clin Oncol 34, 2016 (suppl; abstr e23023)

Alpa Manchandia Nick, Geoff Copper, Weiguo Wu, Cherie Dantone, Asifa Haider, Bryan Fellman, Darren W. Davis, Anil Sood “Characterization of CTCs isolated from patients with recurrent ovarian cancer using an antibody-free CTC isolation device”. J Clin Oncol 34, 2016 (suppl; abstr e17056)

Darren W. Davis, Asifa Haider, Valerie Pierron, Fabien Schmidlin .”Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs”.J Clin Oncol 34, 2016 (suppl; abstr e23025)

Bora Lim, Rashmi Murthy, Summer Jackson,Jie Willey, Jangsoon Lee, Ricardo Alvarez , Carlos Barcenas, Nuhad Ibrahim, Meghan Karuturi, Daniel Booser, Stacy Moulder, Sharon Giordano, Abenaa Brewster, Ronald Walters, Powel Brown, Debu Tripathy, Vicente Valero, and Naoto T. Ueno. Open-label phase Ib study of entinostat (E), and lapatinib (L) alone, and in combination with trastuzumab (T) in patients (pts) with HER2+ metastatic (mHER2+) breast cancer after progression on trastuzumab. J Clin Oncol 34, 2016 (suppl; abstr 609)